J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thouverez, M.
Right arrow Articles by Bertrand, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thouverez, M.
Right arrow Articles by Bertrand, X.
Agricola
Right arrow Articles by Thouverez, M.
Right arrow Articles by Bertrand, X.
J Med Microbiol 52 (2003), 801-806; DOI: 10.1099/jmm.0.05252-0
© 2003 Society for General Microbiology
ISSN 0022-2615

Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital

Michelle Thouverez1, Arno Muller1, Didier Hocquet2, Daniel Talon1 and Xavier Bertrand1

Service d'Hygiène Hospitalière et d'Epidémiologie Moléculaire1 and Service de Bactériologie2, Centre Hospitalier Universitaire Jean Minjoz, Besançon, France

Correspondence Daniel Talon daniel.talon{at}ufc-chu.univ- fcomte.fr

Received March 10, 2003
Accepted May 23, 2003

The objective of this study was to investigate the relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) over a period of 4 years. The antibiotype of all MRSA isolates that were identified during a yearly period of 3 months was determined; 50 consecutive non-replicate MRSA isolates were typed each year. Susceptibility rates to gentamicin, tobramycin and ofloxacin remained stable (95, 16 and 4 %, respectively). In contrast, the proportion of MRSA isolates susceptible to erythromycin increased progressively from 10.5 to 32.5 % (P < 0.001). PFGE analysis of genomic DNA from 200 isolates revealed the presence of 15 different clones. Two epidemic clones were identified, which contained 150 (clone A) and 28 (clone C) isolates. Non-epidemic strains were more frequently susceptible to ofloxacin (31.8 versus 1.1 %) and tobramycin (45.4 versus 16.8 %) than epidemic strains; those isolates that were susceptible to all antibiotics tested belonged to sporadic clones. The increase of erythromycin susceptibility within MRSA isolates was caused by the emergence of clone C. This study suggests that when selection pressure exerted by an antibiotic is insufficient (i.e. below a threshold level), fitness advantages play a predominant role in the dissemination of MRSA clones. The balance between the selection pressure exerted by antibiotics and the disadvantage of lower replication rates of resistant strains in the absence of antibiotics complicates the biological model of clonal dissemination of epidemic MRSA strains.


Abbreviations: DDD, defined daily dose; GR, gentamicin-resistant; GS, gentamicin-susceptible; MRSA, methicillin-resistant Staphylococcus aureus.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
A. Muller, F. Mauny, D. Talon, P. T. Donnan, S. Harbarth, and X. Bertrand
Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis
J. Antimicrob. Chemother., October 1, 2006; 58(4): 878 - 881.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Sola, P. Cortes, H. A. Saka, Cordoba MRSA Collaborative Study Group, A. Vindel, and J. L. Bocco
Evolution and Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Epidemic and Sporadic Clones in Cordoba, Argentina
J. Clin. Microbiol., January 1, 2006; 44(1): 192 - 200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2003 Society for General Microbiology.